CION Cancer Clinics
Why cholangiocarcinoma is often mistaken for secondary cancer | CION Cancer Clinics
Intrahepatic cholangiocarcinoma is often first reported as cancer that has spread to the liver, because its cells look like bowel, stomach or pancreas cancer under the microscope. The real answer comes from the biopsy, the scans and a search for another starting point, read together. This page explains why the mix-up happens, how doctors resolve it and why the right name matters. At CION Cancer Clinics in Hyderabad, our oncologists explain liver cancer in plain words and plan care around you and your family.
On this page
- Why would a bile duct cancer be called secondary cancer?
- What makes this cancer look like spread from elsewhere?
- How do doctors decide it started in the liver?
- What do the words on the biopsy report mean?
- Does the label really change anything?
- What this page cannot tell you
- Common questions about cholangiocarcinoma and secondary cancer
The short answer
Why would a bile duct cancer be called secondary cancer?
Because under the microscope it looks almost exactly like cancer that has spread to the liver from somewhere else. Intrahepatic cholangiocarcinoma starts in the small bile ducts inside the liver, and its cells form glands, just as bowel, stomach, pancreas and lung cancers do when they reach the liver.
This page is about a primary liver cancer
Most cancer found in the liver has in fact come from another organ. If your doctors have already found the starting point, such as the bowel or the breast, this page is not about you. Read what a report of liver metastases means instead.
Who this page is for
It is for the family whose report says "adenocarcinoma in the liver", where every other scan and scope has come back clear and nobody can find where the cancer began. In that situation the cancer may well have started in the liver's own bile ducts. Getting that name right matters, because the treatment, the testing and the chance of surgery are all different.
"Adenocarcinoma" describes how the cells look. It does not by itself say which organ they came from.Where the confusion comes from
What makes this cancer look like spread from elsewhere?
No single feature causes the mix-up. Several ordinary findings point the same wrong way at once.
The cells look the same
Bile duct cells and gut cells are close cousins. When either turns cancerous, the pathologist sees gland-forming cancer cells, and the pattern alone cannot say which organ they came from.
The stains overlap
Pathologists use special stains, called immunohistochemistry, to narrow down the origin. The stains that light up in bile duct cancer also light up in pancreas and stomach cancer, so the report often lists several possibilities.
The liver often looks healthy
Hepatocellular carcinoma (HCC), the commoner primary liver cancer, usually grows in a scarred liver. This cancer often grows in a liver with no cirrhosis, which makes doctors think of spread first.
There may be several spots
Small nodules around the main tumour, or spots elsewhere in the liver, look like the scattered pattern of spread.
The blood tests do not help much
- AFP, the HCC marker, is usually normal
- CA 19-9 can be raised, but so it is in pancreas cancer
- CEA can be raised, as it is in bowel cancer
Not sure whether this applies to you?
Ask an oncologistWorking it out
How do doctors decide it started in the liver?
A biopsy of the liver lump
Unlike HCC, this cancer almost always needs tissue to confirm it. CION arranges the liver biopsy through its diagnostic partners.
A search for another starting point
Depending on the stains, you may be asked to have a scope of the stomach, a colonoscopy, a CT of the chest, or a breast scan. These are looking for a cancer elsewhere that could explain the liver lump.
Careful review of the scans
Radiologists look at how the lump takes up contrast dye, whether the bile ducts beyond it are widened, and whether the liver surface is pulled in. Each is a clue to bile duct origin.
A tumour board discussion
The pathologist, radiologist and oncologists weigh the findings together. When no other starting point is found and the pattern fits, they may name it intrahepatic cholangiocarcinoma.
Testing the tumour's DNA
The tissue is sent for molecular profiling. Certain changes are typical of bile duct cancer and can support the diagnosis as well as guide treatment.
On your report
What do the words on the biopsy report mean?
- Adenocarcinoma
- A cancer that forms glands. Bile duct, bowel, stomach, pancreas and lung cancers can all be adenocarcinomas.
- Metastatic adenocarcinoma, primary to be ruled out
- The pathologist is saying the cells could have come from elsewhere and asking your doctors to look. It is a request, not a final verdict.
- CK7 positive, CK20 negative
- Results of two common stains. This pattern fits bile duct cancer but also fits pancreas, stomach and lung cancer.
- Pancreatobiliary origin
- The cells look like they came from the pancreas or the bile ducts. The scans usually decide between the two.
- Cancer of unknown primary
- Used when a full search finds no starting point. Some of these cases are later recognised as cancers that began in the liver's bile ducts.
- Satellite nodules
- Small tumour spots close to the main lump. They are part of the same cancer, not a separate one.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
Does the label really change anything?
The name decides the plan. A bile duct cancer confined to one part of the liver may be removable by surgery, and its chemotherapy differs from that for bowel or stomach cancer. Read why the difference changes treatment.
Treatment can start even while the label is uncertain. Doctors choose a plan that suits the most likely origin, and DNA testing of the tumour often narrows it further.
They are how a primary liver cancer is told apart from spread. Skipping them risks months on the wrong treatment. Ask your team which tests are essential and which can run alongside treatment planning.
Pathology review is routine in difficult cases, and good doctors expect it. A pathology second opinion uses the same tissue blocks, so no new biopsy is usually needed.
Being straight with you
What this page cannot tell you
It cannot tell you what your own lump is. Only the pathologist who has looked at the tissue, working with the radiologist and the oncologists who have seen every scan, can say whether a cancer began in the liver or somewhere else. Even then, the honest answer is sometimes "most likely", and the team will tell you that plainly.
Who this does not apply to
If the starting point has been found, such as a bowel cancer that has spread to the liver, that is secondary cancer and is treated as the original cancer. Bowel cancer in the liver has its own guidance on the colon cancer pages. Gallbladder cancer is a separate disease too. And if you have not yet had a biopsy, nobody can say what kind of cancer it is.
Why the DNA test matters here
Every bile duct cancer should have its DNA tested, because some carry changes that targeted medicines can act on. Not every tumour has one, and some of these medicines are hard to get in India or reachable only through trials or import. See why molecular testing matters.
If your report says "primary to be ruled out" and the search has stalled, call the helpline. The tumour board can review the slides and scans you already have.Questions we are asked
Common questions about cholangiocarcinoma and secondary cancer
Can a liver biopsy alone prove it is cholangiocarcinoma?
Not always. The biopsy shows adenocarcinoma and the stains narrow the possibilities, but they overlap with other organs. The diagnosis usually rests on the biopsy, the scans and a search that finds no other starting point, weighed together. DNA testing of the tumour can add further support.
Why do they want a colonoscopy when the cancer is in my liver?
Bowel cancer is one of the commonest cancers to spread to the liver, and its cells can look like bile duct cancer. A colonoscopy rules it in or out. If it is clear, a primary liver cancer becomes more likely. The test is part of getting the right name and the right treatment.
Is cholangiocarcinoma the same as liver cancer?
It is one kind of primary liver cancer, starting in the bile ducts inside the liver rather than in the main liver cells. HCC is the other main kind. They behave differently and are treated differently. Read how it differs from HCC.
Does a raised CA 19-9 confirm bile duct cancer?
No. CA 19-9 can be raised in bile duct cancer, but also in pancreas and stomach cancer, and in harmless conditions such as a blocked bile duct or an infection. It can support a diagnosis. It cannot make one on its own, and a normal value does not rule cancer out.
My report says cancer of unknown primary. Could it be this?
It could. Some cancers labelled unknown primary, with the main lump in the liver, turn out to have begun in the liver's bile ducts. Ask whether the tumour board has considered it and whether DNA testing has been done. Your team can explain where your own case stands.
Should we get a second opinion on the pathology?
In a difficult case like this it is reasonable. A second pathologist looks at the same tissue blocks and slides, so you usually do not need another biopsy. Collect the blocks, the slides and every scan disc before you travel, so nothing has to be repeated.
Can treatment start before the label is certain?
Often, yes. When the search is complete but the origin is still uncertain, oncologists choose the plan that suits the most likely cancer. Waiting indefinitely for certainty is rarely helpful. Ask your team what they think is most likely and why.
What should we bring to a consultation at CION?
Bring the biopsy report, the stain results, the tissue blocks if you have them, every scan on disc with its report, and all blood test results including CA 19-9 and CEA. The tumour board can then review the whole picture. One helpline serves every CION centre if you are unsure what to collect.
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Bile Duct Cancer Diagnostic Tests
- National Cancer Institute — Carcinoma of Unknown Primary—Patient Version
- Cancer Research UK — Secondary liver cancer
- National Cancer Institute — What Is Bile Duct Cancer (Cholangiocarcinoma)?
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Talk to us
Has the search for where it started stalled?
Send us the biopsy report, the stains and the scans you already have, and the tumour board can review them together. One helpline serves every CION centre.